Major Coronary Event
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events (NCT00327418) | Pfizer | 1997-01-01 |
Track Major Coronary Event automatically
Every clearance here is in the API, with alerts when new ones post.